Soc. Generale Discount Zert GS 28.../ DE000SV744G4 /
2024-06-05 9:35:27 PM | Chg.+0.170 | Bid8:05:16 AM | Ask8:05:16 AM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
311.770EUR | +0.05% | 311.630 Bid Size: 200 |
311.870 Ask Size: 200 |
Goldman Sachs Group ... | - USD | 2024-06-28 | Call |
GlobeNewswire
1:53 AM
Structure Therapeutics Announces Pricing of Upsized $476 Million Public Offering
GlobeNewswire
06-05
DBV Technologies to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
06-05
Revolution Medicines to Participate in Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
06-05
Xenon Pharmaceuticals to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
06-05
Sterling Check Corp. Investigated by Block & Leviton; Investors Are Encouraged to Contact the Firm
GlobeNewswire
06-05
Madrigal Pharmaceuticals to Participate in the Goldman Sachs 45th Annual Global Healthcare Conferenc...
GlobeNewswire
06-05
Passage Bio to Present at Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
06-05
SpringWorks Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conferenc...
GlobeNewswire
06-05
Apellis Pharmaceuticals to Host a Fireside Chat at the Goldman Sachs 45th Annual Global Healthcare C...
GlobeNewswire
06-05
Amicus Therapeutics to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
06-05
Krystal Biotech to Present at Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
06-05
EyePoint Pharmaceuticals to Present at Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
05-09
Attovia Therapeutics Raises $105 Million Oversubscribed Series B Financing Led by Goldman Sachs Alte...
GlobeNewswire
04-11
C.K. McWhorter Continues Goldman Sachs Communications: Potential Strong Partnership Ties